Stein Gold, L. ., K. . Eyerich, H. . Sofen, P. . Herranz, L. . Kircik, T. . Bewley, E. . Wolf, G. . Gallo, Y. . Ding, F. E. . Yang, I. . Pau-Charles, and M. . Gooderham. “Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s274, doi:10.25251/skin.7.supp.274.